| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 02/26/2008 | US7335723 Melanin-concentrating hormone antagonists |
| 02/26/2008 | US7335645 For prophylaxis or treatment of skin or mucosa, autoimmune diseases and inflammation |
| 02/26/2008 | US7335632 Selectively inhibit memapsin 2 beta -secretase activity relative to memapsin 1 beta -secretase activity; Alzheimer's disease |
| 02/26/2008 | US7335516 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 02/26/2008 | US7335495 Washing leaves of Porteresia coarctata with sterile sea water, growing fungus on washed leaves; identifying, purification, transferring purified colony; growing culture medial, removing biomass; freeze drying, solvent extraction |
| 02/26/2008 | US7335492 Process for partitioning of proteins |
| 02/26/2008 | CA2138931C Method for determining platelet aggregation |
| 02/21/2008 | WO2008020474A1 Method of producing colistin bulk powder |
| 02/21/2008 | WO2008020108A1 Peptides which are immunogenic in relation to the genuses listeria and mycobacterium, antibodies and uses of these |
| 02/21/2008 | WO2008019406A2 A peptide possessing anti-anthrax activity |
| 02/21/2008 | WO2007127457A3 Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof |
| 02/21/2008 | WO2007120463A3 Compositions and methods for modulation of nek2 kinase activity |
| 02/21/2008 | US20080045721 Thiazole-oxime chemical intermediates to cephalosporin-linked vancomycin derivatives which have use against antibiotic-resistant bacteria including methicillin-resistant Staphylococci aureus (MRSA) |
| 02/21/2008 | US20080045693 Novel flea saliva protein |
| 02/21/2008 | US20080045480 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 02/21/2008 | US20080045461 N-terminally modified glp-1 receptor modulators |
| 02/21/2008 | US20080045460 Treatment of prostate cancer by inhibiting lyn-tyrosine kinase |
| 02/21/2008 | US20080045459 Orally administered peptides synergize statin activity |
| 02/21/2008 | US20080045458 synthetic polypeptides; isolated and purified from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent for reducing wrinkles; inhibits calcium uptake; encoded from nucleic acid; analgesic or insecticide |
| 02/21/2008 | US20080045457 Ancestral Hepatitis C virus envelope protein sequence |
| 02/21/2008 | US20080044837 antibody that binds to the extracellular portion of the human Programmed Death-1 (PD-1) receptor at a membrane proximal region; identifying a modulator of CD28 |
| 02/21/2008 | US20080044484 Use of polymeric nanoparticles for vaccine delivery |
| 02/21/2008 | US20080044463 Bradykinin B2 Receptor Antagonist Peptide From Amphibian Skin |
| 02/21/2008 | US20080044433 Epitopes of hepatitis C virus |
| 02/21/2008 | US20080044429 Fc.gamma.RIIB-Specific Antibodies and Methods of Use Thereof |
| 02/21/2008 | CA2678051A1 Peptides that target to tumor blood vessels of lung cancer and applications thereof |
| 02/21/2008 | CA2660178A1 Promiscuous her-2/neu cd4 t cell epitopes |
| 02/21/2008 | CA2659655A1 Salicylanilides enhance oral delivery of therapeutic peptides |
| 02/20/2008 | EP1890150A1 Determination of agonistic autoantibodies associated with humoral kidney rejection |
| 02/20/2008 | EP1889851A1 PAX2 and PAX8 as targets for immunologic and molecular tumour treatment strategies |
| 02/20/2008 | EP1888775A1 Method for measuring effectively the activity of cytotoxic t lymphocyte in human and out-bred animals |
| 02/20/2008 | EP1888642A1 Binding partners of the placental growth factor, especially antibodies directed against the placental growth factor, production and use thereof |
| 02/20/2008 | EP1888111A1 Modulation of cholesteryl ester transfer protein (cetp) activity |
| 02/20/2008 | EP1404704B9 Bridged bicyclic serine protease inhibitors |
| 02/20/2008 | EP1064010B1 Peptide compositions and formulations and use of same |
| 02/20/2008 | CN101128207A Oxytocin receptor antagonists and their use for the treatment of pulmonary related diseases |
| 02/20/2008 | CN100369928C Blood pressure lowering polypeptide of corn gluten powder, its separation method and application |
| 02/19/2008 | USRE40089 Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen precursor |
| 02/19/2008 | US7332567 Fret protease assays for clostridial toxins |
| 02/19/2008 | US7332474 Peptides and related compounds having thrombopoietic activity |
| 02/19/2008 | US7332473 derived from a PACAP or VIP peptide; can inhibit tautomerization in a solution; regressive neurodegenerative diseases, erectile dysfunction, and bronchial asthma; inhibited isomerization and high stability during the production and storage |
| 02/19/2008 | US7332472 Isomeric mixture of a cyclosporine analogue modified at the 1-amino acid residue with a 1,3-diene substituent; antiinflammatory agents; autoimmune disease; side effect reduction; reduced toxicity |
| 02/19/2008 | US7332356 Fluorescent dye binding peptides |
| 02/19/2008 | US7331920 Glycopeptide antibiotics, combinational libraries of glycopeptide antibiotics and methods of producing same |
| 02/14/2008 | WO2008018792A2 Cyclic angiotensin analogs |
| 02/14/2008 | WO2008018544A1 Sulfonamide compound or salt thereof |
| 02/14/2008 | WO2008017734A1 Polymyxin derivatives and uses thereof |
| 02/14/2008 | WO2007144554A3 Gnrh (gonadotropin-releasing hormone) peptide variants |
| 02/14/2008 | WO2007096662A3 Cancer imaging and treatment |
| 02/14/2008 | US20080039611 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/14/2008 | US20080039404 Bifunctional analgesic compounds for opioid receptor agonists and neurokinin-1 receptor antagonists |
| 02/14/2008 | US20080039403 Exposing the cancer cell to a peptide has antiestrotrophic activity; inhibit estrogen receptor dependent cell proliferation; breast cancer |
| 02/14/2008 | US20080039402 Peptides and Peptidomimetics Binding to Cd23 |
| 02/14/2008 | US20080039401 For allergy such as asthma; modulating interleukin (IL)-9 expression |
| 02/14/2008 | US20080039384 Antiangiogenic Peptides |
| 02/14/2008 | US20080039376 Use of Cyclic Anabaenopeptin-type Peptides for the Treatment of a Condition Wherein Inhibition of Carboxypeptidase U is Beneficial, Novel Anabaenopeptin Derivatives and Intermediates Thereof |
| 02/14/2008 | US20080039374 Cross-lined glycopeptide-cephalosporin antibiotics |
| 02/14/2008 | US20080039341 Unstructured recombinant polymers and uses thereof |
| 02/14/2008 | US20080038838 Dioxin-Binding Material and Method of Detecting or Quantifying Dioxin |
| 02/14/2008 | US20080038756 Botulinum toxin substrate comprising fluorphore and clostridial toxin recognition sequence for use in detecting clostridial protease activity |
| 02/14/2008 | US20080038349 Peptide-Pna Chimera Targeting Inducible Nitric Oxide Synthetase |
| 02/14/2008 | US20080038285 Method for Identifying and Quantifying of Tumour-Associated |
| 02/14/2008 | US20080038265 Antibodies to Erythropoietin Receptor and Uses Thereof |
| 02/14/2008 | CA2694289A1 Polymyxin derivatives and uses thereof |
| 02/14/2008 | CA2660424A1 Sulfonamide compound or salt thereof |
| 02/14/2008 | CA2656816A1 Tetrazolyl macrocyclic hepatitis c serine protease inhibitors |
| 02/13/2008 | EP1887016A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator |
| 02/13/2008 | EP1885855A2 Cytokine receptor modulators and uses thereof |
| 02/13/2008 | EP1885743A1 BACKBONE CYCLIZED MELANOCORTIN STIMULATING HORMONE ( alpha S ) ANALOGS |
| 02/13/2008 | EP1885742A1 Compositions for targeting amine oxidases in vivo |
| 02/13/2008 | EP1578785B1 Peptides that bind to the heparin binding domain of vegf and vegfr-2 |
| 02/13/2008 | EP1379283B1 Identification of target-specific folding sites in peptides and proteins |
| 02/13/2008 | EP1082126B1 Novel peptides |
| 02/13/2008 | EP0906335B1 Ebv type b ctl epitopes |
| 02/13/2008 | EP0833652B1 Novel kappa receptor selective opioid peptides |
| 02/13/2008 | CN101124239A Modulation of ovulation |
| 02/13/2008 | CN101123878A L-threonine derivatives of high therapeutic index |
| 02/13/2008 | CN100368431C Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumors |
| 02/13/2008 | CN100368381C Tetra-(alpha-amino-acid or dipeptide) complexes of di-copper and synthetic method, and SOD loke activity |
| 02/13/2008 | CN100368014C Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 02/12/2008 | US7329726 Physiologically active peptides |
| 02/12/2008 | US7329644 Preparation and use of cyclic and branched peptides and their labelled derivatives as therapeutic agents, cholecystokinin agonists or antagonists, and diagnostic agents to identify and locate tumours |
| 02/12/2008 | US7329639 Containing one or more epitopes recognized by and binding to a BAT monoclonal antibody; diagnosing and treating cancer; cancer vaccines |
| 02/12/2008 | US7329541 Zinc finger binding domains for GNN |
| 02/12/2008 | US7329496 Sequencing of surface immobilized polymers utilizing microflourescence detection |
| 02/12/2008 | CA2315532C Cyclopeptide derivatives with integrin inhibitor properties |
| 02/12/2008 | CA2234716C Peptides for treatment of inflammation and shock |
| 02/12/2008 | CA2163196C Regulation of antigen presentation |
| 02/12/2008 | CA2131729C Helicobacter pylori proteins useful for vaccines and diagnostics |
| 02/12/2008 | CA2131153C Peptides stimulating cytotoxic lymphocytes response to hiv-i gp 160 |
| 02/12/2008 | CA2090485C Method and apparatus for the rapid synthesis of substrate-bound or free peptides or oligonucleotides, flat material synthesized in this way and the use of such material |
| 02/07/2008 | WO2008016276A1 Transmembrane delivery peptide and bio-material comprising the same |
| 02/07/2008 | WO2008015218A2 Method for diagnosis of a disease involving an anti-at1-receptor antibody |
| 02/07/2008 | WO2008014613A1 Multifunctional bioactive compounds |
| 02/07/2008 | WO2008014603A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/07/2008 | WO2007117564A3 Clay-binding peptides and methods of use |
| 02/07/2008 | US20080033061 Cation conducting gabaa receptors and their use |
| 02/07/2008 | US20080033003 Camptothecins Conjugated in Position 7 to Cyclic Peptides as Cytostatic Agents |
| 02/07/2008 | US20080032947 Pka ligands and polynucleotides encoding pka ligands |
| 02/07/2008 | US20080032917 Flavivirus protease substrates and inhibitors |